Literature DB >> 10524475

Short- and long-term outcomes of children with complex regional pain syndrome type I treated with exercise therapy.

D D Sherry1, C A Wallace, C Kelley, M Kidder, L Sapp.   

Abstract

OBJECTIVE: To report the initial and long-term outcome after an intensive exercise therapy program for childhood complex regional pain syndrome, type I (CRPS).
DESIGN: Prospective follow-up.
SETTING: A children's hospital.
SUBJECTS: We followed 103 children (87 girls; mean age = 13.0 years) with CRPS. Forty-nine subjects were followed for more than 2 years (mean = 5 years 3 months).
INTERVENTIONS: An intensive exercise program (most received a daily program of 4 hours of aerobic, functionally directed exercises, 1-2 hours of hydrotherapy, and desensitization). No medications or modalities were used. All had a screening psychological evaluation, and 79 (77%) were referred for psychological counseling. MAIN OUTCOME MEASURES: Outcomes included pain, presence of physical dysfunction, or recurrent episodes of CRPS or other disproportional musculoskeletal pain.
RESULTS: The mean duration of exercise therapy was 14 days, but over the past 2 years has decreased to 6 days. Ninety-five children (92%) initially became symptom free. Of those followed for more than 2 years, 43 (88%) were symptom free (15, or 31 %, of these patients had had a reoccurrence), 5 (10%) were fully functional but had some continued pain, and 1 (2%) had functional limitations. The median time to recurrence was 2 months; 79% of the recurrences were during the first 6 months after treatment.
CONCLUSION: Intense exercise therapy is effective in initially treating childhood CRPS and is associated with low rate of long-term symptoms or dysfunction.

Entities:  

Mesh:

Year:  1999        PMID: 10524475     DOI: 10.1097/00002508-199909000-00009

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  53 in total

Review 1.  Complex regional pain syndromes.

Authors:  R Baron; G Wasner
Journal:  Curr Pain Headache Rep       Date:  2001-04

2.  [Please don't hurt me!: a plea against invasive procedures in children and adolescents with complex regional pain syndrome (CRPS)].

Authors:  B Zernikow; M Dobe; G Hirschfeld; M Blankenburg; M Reuther; C Maier
Journal:  Schmerz       Date:  2012-08       Impact factor: 1.107

Review 3.  The Biopsychosocialspiritual Impact of Chronic Pain, Chronic Illness, and Physical Disabilities in Adolescence.

Authors:  Melissa E A Geraghty; Dawn C Buse
Journal:  Curr Pain Headache Rep       Date:  2015-11

Review 4.  Complex pain in children and young people; part 2: management.

Authors:  S Rastogi; K F McCarthy
Journal:  BJA Educ       Date:  2018-01-27

5.  [CRPS type I psychological origin-case report].

Authors:  J Beckmann; F Köck; J Grifka; N Borisch
Journal:  Z Rheumatol       Date:  2005-11       Impact factor: 1.372

6.  Adolescent chronic pain and disability: A review of the current evidence in assessment and treatment.

Authors:  Christopher Eccleston; Jacqueline Clinch
Journal:  Paediatr Child Health       Date:  2007-02       Impact factor: 2.253

7.  Effects of Aquatic Therapy and Land-Based Therapy versus Land-Based Therapy Alone on Range of Motion, Edema, and Function after Hip or Knee Replacement: A Systematic Review and Meta-analysis.

Authors:  Alison J Gibson; Nora Shields
Journal:  Physiother Can       Date:  2015       Impact factor: 1.037

8.  Complex Regional Pain Syndrome.

Authors:  Ok Yung Chung; Stephen P. Bruehl
Journal:  Curr Treat Options Neurol       Date:  2003-11       Impact factor: 3.598

9.  The Pharmacological Management of Complex Regional Pain Syndrome in Pediatric Patients.

Authors:  Glyn Williams; Richard Howard
Journal:  Paediatr Drugs       Date:  2016-08       Impact factor: 3.022

10.  Evidence based guidelines for complex regional pain syndrome type 1.

Authors:  Roberto S Perez; Paul E Zollinger; Pieter U Dijkstra; Ilona L Thomassen-Hilgersom; Wouter W Zuurmond; Kitty Cj Rosenbrand; Jan H Geertzen
Journal:  BMC Neurol       Date:  2010-03-31       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.